Introduction
============

Hepatocellular carcinoma (HCC), the fifth common cancer in the world, ranks the third in cancer-related death [@B1]. Currently, the diagnosis of HCC is still poor, and therapeutic options are limited. Many HCC patients are not diagnosed until they are in advanced stages when curative therapies are too late to be applied; while for those patients who are eligible for surgical resection, liver transplantation or local ablation, although their life qualities could be improved by these therapies, their overall survival rates are still low. Therefore, novel biomarkers and therapeutic approaches are urgently needed to improve the overall survival of HCC patients.

Circular RNAs (circRNAs) are a new class of abundant endogenous functional non-coding RNAs (ncRNAs), and have been demonstrated to play important roles in different types of cancer, including gastric cancer, lung cancer, and HCC [@B2]-[@B4]. They form covalently closed continuous loop structures with neither polarity nor polyadenylated tails, which make them more stable and abundant than their canonical linear transcripts from the same genes in cells [@B5], [@B6]. Except for tissues, circRNAs can also be found in different body fluids, such as saliva, blood, and urine, suggesting that they may serve as non-invasive circulating biomarkers for cancer diagnosis [@B7]. Studies showed that circRNAs may regulate gene expression at transcriptional, post-transcriptional, and translational levels. Specifically, circular exonic circRNAs, which predominantly exist in cytoplasm, harbor microRNA (miRNA) response elements (MREs), and may function as miRNA sponges by competitively binding to specific miRNAs to reduce their expression and function, resulting in enhanced expression of target genes of these miRNAs; while circular intronic RNAs or exon-intron circRNAs are mainly accumulate in the nucleus, and may regulate gene transcription and post-transcription [@B5], [@B8]-[@B10]. These suggest that circRNAs may participate in various biological processes, such as cell proliferation, migration, invasion and metastasis, as well as apoptosis, and thus contribute to cancer progression.

Most recently, some circRNAs have been reported to be deregulated in HCC tissues, and the deregulation of these circRNAs may not only associate with clinicopathological features of HCC patients, but also impact on HCC progression by targeting specific miRNAs and proteins. Several circRNAs, such as circZKSCAN1, hsa_circ_0004018, and hsa_circ_0005075, have been identified as promising biomarkers for HCC diagnosis; whereas circMTO1 and circ-ITCH may serve as potential prognostic biomarkers for poor survival of HCC patients [@B11]-[@B15]. Furthermore, some circRNAs have been reported to interfere with HCC progression by modulating the proliferation, apoptosis, migration and invasion *via* targeting different miRNAs and proteins. For example, circMTO1 inhibits the proliferation of HCC cells by sponging miR-9 and increasing the expression of miR-9 target gene p21, a cell cycle inhibitory protein; hsa_circ_100338 promotes the migration and invasion of HCC cells by targeting miR-141; while ciRS-7 facilitates the proliferation and invasion of HCC cells by competitively binding to hsa-miR-7-5p (miR-7) and promoting the expression of multiple miR-7 target genes, including CCNE1, PIK3CD, and EGFR [@B14], [@B16]-[@B19]. These results indicate that circRNAs may play critical roles in HCC progression.

In the current study, we downloaded the HCC-associated circRNA expression profiles GSE94508 and GSE97332 from the Gene Expression Omnibus database (GEO), analyzed the differentially expressed circRNAs (DECs) in both profiles between paired HCC and non-tumor liver tissues, and investigated their possible target genes and pathways involved in HCC using bioinformatic approaches, to provided possible functions and underlying mechanisms of these DECs in HCC tumorigenesis and progression.

Materials and methods
=====================

Microarray analysis of gene expression
--------------------------------------

Two circRNA expression profiles, GSE94508 and GSE97332, were downloaded from the GEO ([www.ncbi.nlm.nih.gov/geo/](http://www.ncbi.nlm.nih.gov/geo/)), both of which were completed on the Agilent-069978 Arraystar Human CircRNA microarray V1 GPL19978 platform [@B20]. The GSE94508 dataset contained 5 pairs of HCC and paracancerous liver tissues, and the GSE97332 dataset contained 7 pairs of HCC and matched non-tumor liver tissues.

Identification of DECs
----------------------

GEO2R [@B21] was used to analysis the raw data TXT files downloaded from GEO. The absolute value of log fold change \> 1.0 and *p* value \<0.05 were used as cut-off criteria. CircRNAs with statistical significance between HCC and non-tumor tissues in GSE94508 and GSE97332 were screened, separately. Then, circRNAs up-regulated or down-regulated in both profiles were selected and identified.

Functional enrichment analysis
------------------------------

Gene ontolog (GO) annotation, including biological process, cellular component, and molecular function, was analyzed using the Database for Annotation, Visualization, and Integrated Discovery (DAVID; https://david. ncifcrf.gov) [@B22]-[@B24]. Kyoto Encyclopedia of Genes and Genomes (KEGG) and Panther (http.//[www.pantherdb.org/](http://www.pantherdb.org/)) pathway analyses were used to classify genomic and gene functional information [@B25]-[@B26]. The significant enrichment results were obtained with *p* values \<0.05.

Prediction of circRNA-miRNA and miRNA-mRNA interactions
-------------------------------------------------------

Online tools miRDB (http.//[www.mirdb.org/](http://www.mirdb.org/)) and circinteractome (https.//circinteractome.nia.nih.gov/) were used to predict the possible interactions between circRNAs and miRNAs [@B27]-[@B29]; miRDB and TargetScan (http.//[www.targetscan.org/mamm_31/](http://www.targetscan.org/mamm_31/)) were applied for predicting target genes of the four essential miRNAs; while mirTarBase (http.//mirtarbase.mbc.nctu.edu.tw/php/index.php) was used to obtain experimentally strongly supported targets genes (by Reporter assay, Western blot, or qPCR) of these miRNAs [@B30]-[@B32].

Construction of protein-protein interaction (PPI) network
---------------------------------------------------------

Experimentally supported target genes of the four essential miRNAs were put into the Search Tool for the Retrieval of Interacting Genes database (STRING; https.//string-db.org/), and an interaction network chart with a combined score \> 0.4 was saved and exported [@B33]. Subsequently, top 50 genes with more counts of interacting protein were selected, and the PPI network was visualized using Cytoscape software (version 3.6.1; http.//cytoscape.org/) [@B34]. The values of gene interactions predicted by STRING were also imported into Cytoscape to identify hub genes among potential targets.

Cell culture
------------

HCC cell line HepG2 was cultured in Dulbecco\'s Modified Eagle Medium (DMEM, Gibco, USA), and human normal liver cell line L02 was cultured in 1640 in a humidified 37℃ incubator with 5% CO~2~. Both media were supplemented with 10% FBS (Gibco.USA), 2 mmol/L L-glutamine and 100U/mL penicillin/100 μg/mL streptomycin (Life Technologies, CA, USA).

RNA extraction and quantitative real-time polymerase chain reaction (qRT-PCR)
-----------------------------------------------------------------------------

Total RNAs from HepG2 and L02 cells were extracted using TRIzol reagent (Life Technologies, CA, USA) according to the manufacture\'s protocol. RNA quality and quantity was meatured using Synergy H4 Hybrid Multi-Mode Microplate Reader (BioTek Instruments Inc, Winooski, VT, USA). Total RNAs were reversely transcribe using HiScript Q RT SuperMix for qPCR with gDNA wiper (Vazyme Biotech, Nanjing, China), and qPCR assays were performed in triplicate using AceQ qPCR SYBR Green Master Mix kit (Vazyme Biotech, Nanjing, China) on the ABI QuantStudio 3 real-time PCR system (ThermoFisher Scientific, USA). The divergent primers used for detecting circRNAs were synthesized from Shanghai Generay Biotech (Shanghai, China), and β-actin was used as an internal control. The sequences of primers for qPCR were listed in Table [1](#T1){ref-type="table"}, and the specificity of PCR products was evaluated by dissociation curve analysis and the Sanger sequencing (Sango Biotech, Shanghai, China).

Statistical analysis
--------------------

Statistical analyses were performed using GraphPad Prism 5 (GraphPad Software, CA, USA). All Data were shown as mean ± SEM. Student\'s *t*-test was used to compare the differences of circRNA expression between L02 and HepG2 cells, and a *p* value \<0.05 was considered statistically significant.

Results
=======

Selection of DECs
-----------------

Two circRNA expression profiles, including GSE94508 and GSE97332, were downloaded from GEO, and GEO2R method was applied to analysis DECs between HCC liver tissues and paired non-tumor tissues. Results showed that many circRNAs were differentially expressed in HCC tissues. In GSE94508, 560 circRNAs were identified to be differentially expressed, including 214 up-regulated and 346 down-regulated circRNAs; while in GSE97332, 892 differentially expressed circRNAs were identified, including 453 up-regulated and 439 down-regulated circRNAs. Among them, 87 circRNAs, including 76 up-regulated and 11 down-regulated circRNAs, were observed in both circRNA expression profiles (Figure [1](#F1){ref-type="fig"}A and [1](#F1){ref-type="fig"}B, and Table [2](#T2){ref-type="table"}).

GO and pathway analysis of the host genes of DECs
-------------------------------------------------

Since some circRNAs function by regulating their parental genes, GO analysis was carried out to annotate the host genes of the 87 DECs. Biological process analysis showed that these host genes were enriched in cell adhesion, positive/ negative regulation of gene expression, and Golgi organization. Cellular component analysis indicated that these host genes were remarkably enriched in cytosol, membrane and Golgi apparatus. For molecular function, the most significantly enriched GO term was protein binding (Figure [2](#F2){ref-type="fig"}A). KEGG and Panther pathway analysis demonstrated that tight junction, aldosterone synthesis and secretion, inflammation mediated by chemokine and cytokine signaling pathway, and Wnt signaling pathway may involved in circRNA-mediated regulatory network in the pathogenesis of HCC (Figure [2](#F2){ref-type="fig"}B).

Prediction of circRNA-miRNA interactions
----------------------------------------

Increasing evidences demonstrate that circRNAs may competitively bind to miRNAs and increase the expression of the target genes of these miRNAs. For the 87 DECs, prediction by online tools miRDB and circinteractome revealed 343 and 1085 circRNA-miRNA interactions, respectively. Furthermore, 20 consensus miRNAs from both prediction tools were identified, and DECs potentially bind to these miRNAs were presented in Table [3](#T3){ref-type="table"}. Results showed that one specific circRNA may bind to more miRNAs, while different circRNAs could interact with one specific miRNA, indicating that circRNAs may impact on HCC progression by modulating various miRNAs.

Target genes of some essential miRNAs and their function analysis
-----------------------------------------------------------------

Among the 20 consensus miRNAs, four essential miRNAs, including miR-7, hsa-miR-145-5p (miR-145), hsa-miR-203a-3p (miR-203a), and hsa-miR-192-5p (miR-192), were reported to be down-regulated in HCC, and play pivotal roles in HCC progression by targeting multiple protein-coding genes. Using online tools miRDB and TargetScan, 1480 target genes of these four miRNAs were predicted, and then presented in Venn diagram (Figure [3](#F3){ref-type="fig"}). Two common target genes (SLC4A4 and ZDHHC9) were found for miR-7, miR-145 and miR-203a; two target genes (CPEB4, DYRK1A) were found for miR-145, miR-203a, and miR-192; and one target gene (MECP2) for miR-7, miR-203a and miR-192; while none of these genes was predicted to be targeted by all the four miRNAs. KEGG and Panther pathway analyses revealed that these target genes were involved in many HCC-associated signaling pathways, such as Wnt, TGF-β, and Ras, suggesting their possible roles in HCC pathogenesis (Figure [4](#F4){ref-type="fig"}).

Construction of essential miRNAs-centered regulatory network
------------------------------------------------------------

To analysis the significance of target genes of the four essential miRNAs, their experimentally strongly supported targets genes were obtained from mirTarBase. Among these, some genes, such as ABCC1 and CUL5, have been demonstrated to be targeted by more than one essential miRNAs, suggesting a complex regulatory network involving the four essential miRNAs and their target genes. Furthermore, protein-protein interaction (PPI) was analyzed using online tool STRING, and the PPI network of the top 50 genes which have more counts of interacting protein was visualized using Cytoscape software (Figure [5](#F5){ref-type="fig"}). Subsequently, four essential miRNAs and their potential interacting circRNAs were combined into the regulatory network. In this figure, proteins with bigger circles showed more interactions with other proteins than those with smaller circles.

Validation of DECs
------------------

To verify the deregulation of DECs, nine of them were randomly chosen for further validation. The expression of these DECs in L02 and HepG2 cells were detected using qRT-PCR, and the specificity of qPCR products was evaluated by dissociation curve analysis and the Sanger sequencing. Among them, the expression of two circRNAs, including hsa_circ_0001489 and hsa_circ_0039053, was low in both cell lines, and was failed to be detected. Six circRNAs were validated to be greatly up-regulated in HepG2 cells compared with L02 cells, including hsa_circ_0001806, hsa_circ_0003528, hsa_circ_0008583, hsa_circ_0009910, hsa_circ_0032704, and hsa_circ_0065214 (Figure [6](#F6){ref-type="fig"}A-[6](#F6){ref-type="fig"}F); while hsa_circ_0007762 was found to be greatly down-regulated in HepG2 cells compared with L02 cells (Figure [6](#F6){ref-type="fig"}G). The expression pattern of these circRNAs in HCC cell lines was similar to that in HCC specimens from the two GEO HCC datasets.

Discussion
==========

Emerging evidences indicate that circRNAs are frequently deregulated in HCC tissues. Some deregulated circRNAs may serve as biomarkers for HCC diagnosis and prognosis, while others could regulate HCC progression through diverse mechanisms by functioning as miRNA sponges, RNA-binding protein sponges, or transcriptional regulators [@B4]. In the current study, we identified 87 DECs from the HCC circRNA expression profiles of GSE94508 and GSE97332 downloaded from GEO database, and analyzed the functions and possible underlying mechanisms of these DECs in HCC tumorigenesis and progression using bioinformatic methods. In the meantime, the deregulation of some DECs was validated in HCC cells by qRT-PCR and the Sanger sequencing.

Among the 87 DECs identified in our study, four up-regulated circRNAs, including hsa_circ_0000673, hsa_circRNA_0072088, hsa_circ_0009910, and hsa_circ_0067934, have been reported to play important roles in the progression of different cancers, such as HCC, gastric cancer (GC), colorectal cancer (CRC), and esophageal squamous cell carcinoma (ESCC) [@B35]-[@B40]. Two circRNAs, hsa_circ_0000673 and hsa_circRNA_0072088, were up-regulated in HCC and lung cancer, separately, and play tumor-promoting roles by modulating miR-767-3p/SET axis and miR-4302/znf121/MYC axis, respectively [@B35], [@B37]. However, they were down-regulated, and may act as tumor suppressors in other cancers. Hsa_circ_0000673 was reported to inhibit tumor suppressor gene RUNX3 by targeting miR-532-5p, leading to inhibition of GC progression; while hsa_circRNA_0072088 was found to promote FOXO4 by targeting miR-532-3p, resulting in suppression of CRC development [@B36], [@B38]. Other two circRNAs, hsa_circ_0009910 and hsa_circ_0067934, were demonstrated to be up-regulated in osteosarcoma and ESCC, separately, and play oncogenic roles in these cancers. Hsa_circ_0009910 was capable of sponging miR-499a and enhancing the expression of miR-499 target gene IL6R, and thus accelerating carcinogenesis of osteosarcoma; while hsa_circ_0067934 could promote the proliferation and migration of ESCC cells, and its expression level in ESCC was associated with tumor differentiation and TNM stages [@B39], [@B40]. Interestingly, our study demonstrated the up-regulation of hsa_circ_009910 in HCC, indicating its possible roles in HCC progression. The precise function and mechanisms of this circRNA in HCC is currently under investigation.

Recent research works suggest that some circRNAs may regulate the transcription of their parental genes [@B41]. In the current study, the possible GO functional terms and signaling pathways of the host genes of these DECs were characterized. Results showed that these host genes were enriched in cell adhesion, cytosol, and protein binding, all of which were associated with HCC progression. Pathway analysis from KEGG and Panther demonstrated that tight junction and Wnt signaling pathway are among the most relevant pathways for HCC. Tight junction signaling contributes to pathogenesis of GC and CRC, plays functional roles in epithelial-to-mesenchymal transition and viral entry, and could be used as potential targets for gastrointestinal and liver disease; while Wnt signaling pathway is well known to impact on hepatocarcinogenesis and HCC progression [@B42]-[@B45]. These results suggested that these DECs may participate in HCC progression by regulating their parental genes.

Many miRNAs have been demonstrated to regulate HCC progression by modulating the expression of one or more HCC-associated genes [@B46], [@B47]. However, the functions of miRNAs can be interfered by their possible interaction with circRNAs and lncRNAs. One of the most interesting examples is the interaction between ciRS-7 and miR-7. CiRS-7 is a special and unique natural circRNA which harbors more than 70 binding sites for miR-7. By binding to miR-7, ciRS-7 facilitates the expression of miR-7 target genes, such as CCNE1, PIK3CD, and EGFR, and thus blocks the inhibitory effect of miR-7 on HCC [@B17]-[@B19]. Similarly, circMTO1 and circHIPK3 were found to modulate HCC progression by competitively binding to miR-9 and miR-124-3p, respectively, and thus increasing the expression of multiple oncogenic genes, such as p21, Norch1, AQP3 [@B14], [@B48]. In the current study, the interactions between DECs and miRNAs were predicted. Among all the DECs, hsa_circ_0005428 contains the most number of interactions and could potentially bind to 16 different miRNAs, whereas hsa_circ_0001834 and hsa_circ_000511 have only one potential miRNA binding site. Among the top 20 miRNAs which predispose to interact with DECs, each one contains at least two potential DECs binding sites. Specially, hsa-miR-1248 has as many as 12 DECs binding sites. Given the importance of miRNAs in HCC progression, it is possible that DECs could impact on HCC progression by targeting specific miRNAs to increasing the expression of their target genes.

Among the top 20 miRNAs, four essential miRNAs, including miR-7, miR-145, miR-203, and miR-192, were reported to be down-regulated in HCC, and could inhibit HCC progression by modulating the expression of multiple target genes; while their modulation on target genes may be blocked by their interaction with non-coding RNAs. For example, interaction between miR-7 and ciRS-7 or lncRNA KCNQ1OT1 led to reduced expression of miR-7 and increased expression of miR-7 target genes CCNE1, PIK3CD, EGFR, and ABCC1, resulting in promotion of HCC progression [@B18], [@B19], [@B49]; whereas interaction between miR-145 and lincRNA-ROR or pseudogene OCT4-pg4 led to reduction of this miRNA and increase of miR-145 target genes RAD18, ZEB2, and OCT4, resulting in aggravation of HCC [@B50]-[@B52]. MiR-203 could interact with three lncRNAs, including CRNDE, UCA1 and HULC, and the interaction of which greatly elevated the expression of miR-203 target genes BCAT1, SNAI2, and ADAM9, and thus facilitating HCC progression [@B53]-[@B55]; while miR-192, however, could be blocked by lncRNA HOTTIP, and reduced expression of this miRNA led to exacerbated expression of its target gene GLS1, resulting in enhanced progression of HCC [@B56]. Regarding to their pivotal roles in HCC progression, these four essential miRNAs were selected for further analysis. With their predicted and validated target genes, pathway and protein-protein interaction network analyses were carried out. KEGG and Panther pathway analyses suggested that the predicted target genes of these miRNAs were involved in various pathways, such as Wnt, TGF-β, oxytoxin, and Ras, all of which are closely related to hepatogenesis and HCC progression. A four essential miRNAs-centered circRNA-miRNA-mRNA network was established by combination of the potential interacting DECs of the four miRNAs with the PPI network based on the top 50 experimentally supported target genes of these miRNAs. Results suggested that some target genes of these miRNAs, such as PIK3CA, AKT1, MYC, JUN, SMAD4, and SRC, may impact on cell function by interacting with different molecules in cells and interfering with various signaling pathways, while specific circRNAs may control the expression of these genes by indirectly targeting essential miRNAs. As expected, we found that the expression of two circRNAs, including hsa_circ_0032704 and hsa_circ_0065214, was greatly increased in HCC tissues and cell lines, suggesting that these two circRNAs may function in HCC progression by targeting HCC suppressor genes miR-203a and miR-7, respectively, leading to enhanced expression of oncogenic proteins and promotion of HCC progression. Currently, their functions and molecular mechanisms, including possible interactions with miRNAs, are under investigation.

In conclusion, this study revealed aberrantly expressed circRNAs in HCC, and discussed their possible roles in HCC progression. Further investigations are needed to fully elucidate the functions and underlying mechanisms of these deregulated circRNAs and their regulatory networks in tumorigenesis and HCC progression.
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![**Differentially expressed circular RNAs (DECs) in hepatocellular carcinoma (HCC) compared with paired non-tumor liver tissues.** (A-B) Venn diagram represents the overlap of the identified DECs in HCC tissues from the results of microarray GSE94508 (5 pairs) and GSE97332 (7 pairs). (A) Up-regulated circRNAs in HCC tissues. (B) Down-regulated circRNAs in HCC tissues.](jcav10p3361g001){#F1}

![**Functional annotation of the host genes of DECs.** (A) Gene ontolog (GO) enrichment analyses of the host genes of DECs, including biological process, cellular component, and molecular function. (B) KEGG and Panther pathway enrichment analyses of the host genes of DECs.](jcav10p3361g002){#F2}

![**Venn diagram of target genes of the four essential microRNAs (miRNAs), including hsa-miR-7-5p (miR-7), hsa-miR -145-5p (miR-145), hsa-miR-203a-3p (miR-203), and hsa-miR-192-5p (miR-192).** 1480 target genes of the four miRNAs were predicted using online tools miRDB and TargetScan.](jcav10p3361g003){#F3}

![**Pathway analysis of target genes of the four essential miRNAs.** (A-B) KEGG pathway (A) and Panther pathway (B) functional analyses of these target genes.](jcav10p3361g004){#F4}

![**Essential miRNAs-centered circRNA-miRNA-mRNA network.** The experimentally supported target genes of the four essential miRNAs were obtained using online tool mirTarBase. MiRNA-mRNA interaction was represented as orange edges, protein-protein interaction was represented as blue edges, and circRNA-miRNA interaction was represented as purple edges. PIK3CA, AKT1, MYC, JUN, SMAD4, and SRC were shown as hub target genes as they have more counts of interacting protein.](jcav10p3361g005){#F5}

![**Validation of DECs.** (A-G) The deregulation of seven DECs, including hsa_circ_0001806 (A), hsa_circ_0003528 (B), hsa_circ_0008583 (C), hsa_circ_0009910 (D), hsa_circ_0032704 (E), hsa_circ_0065214 (F), and hsa_circ_0007762 (G), was validated by qRT-PCR and the Sanger sequencing. For each DEC, from left to right: comparison of relative expression of the DEC between HCC tissues and paired non-tumor tissues, as extracted from GSE94508 (five pairs) and GSE97332 (seven pairs), respectively; comparison of relative expression of the DEC between HCC cell line HepG2 and normal liver cell line L02, as determined by qRT-PCR; and the specificity of the divergent PCR products, as verified by the Sanger sequencing of the DEC in back-splice junction. Data were shown as mean ± SEM, and student\'s t-test was used to compare the differences of circRNA expression between two groups.](jcav10p3361g006){#F6}

###### 

Circular RNA (circRNA) primers used for qPCR

  Gene               Forward primer (5\'-3\')   Reverse primer (5\'-3\')
  ------------------ -------------------------- --------------------------
  has_circ_0001806   CCATCCCATCAGTTCATCCT       TTCACCTCCAAAGAGCATCC
  has_circ_0003528   GTAACCAGCAGCCTGGACTC       GCAACTTGCTGACCAGAACA
  has_circ_0008583   TTACGGGAGCAGATGATGAA       CCAAGAAGGAAGATGGGCTA
  has_circ_0009910   CAGGTTCTGGACGTCAAAGG       TCACCTCAGCCATGTGTCTC
  has_circ_0032704   TTGTTCCTCATCGCAGCAGT       ATAGAGGCGCACGTCAAACT
  has_circ_0065214   TCATGTCTGTGGGACTCTGC       GGGCGAGTAATCCTTCACAG
  has_circ_0007762   CATTCAGATGGCACCTTGAC       GTGCCCACATAGAGCCACTT
  β-actin            AGAAAATCTGGCACCACACC       CAGAGGCGTACAGGGATAGC

###### 

Differentially expressed circRNAs (DECs) in hepatocellular carcinoma (HCC)

  No.                           CircRNA ID         Chromosome location          Gene symbol   Accession number
  ----------------------------- ------------------ ---------------------------- ------------- ------------------
  **Up-regulated circRNAs**                                                                   
  1                             hsa_circ_0000291   chr11:35163017-35163328+     CD44          NM_001202557
  2                             hsa_circ_0000511   chr14:20811282-20811431-     RPPH1         NR_002312
  3                             hsa_circ_0000554   chr14:74551677-74551959+     LIN52         NM_001024674
  4                             hsa_circ_0000644   chr15:81195758-81195954-     KIAA1199      NM_018689
  5                             hsa_circ_0000673   chr16:11940357-11940700-     RSL1D1        NM_015659
  6                             hsa_circ_0000747   chr17:27209637-27210251+     FLOT2         NM_004475
  7                             hsa_circ_0000981   chr2:20240809-20240905-      LAPTM4A       NM_014713
  8                             hsa_circ_0001228   chr22:37868480-37870715-     MFNG          NM_002405
  9                             hsa_circ_0001279   chr3:33109721-33110462-      GLB1          NM_001079811
  10                            hsa_circ_0001338   chr3:128824688-128825122-    RAB43         NM_001204883
  11                            hsa_circ_0001489   chr5:59770958-59771235+      PDE4D         NM_001165899
  12                            hsa_circ_0001806   chr8:68018139-68028357+      CSPP1         NM_024790
  13                            hsa_circ_0001828   chr8:142139086-142139265+    DENND3        NM_014957
  14                            hsa_circ_0001834   chr9:2017333-2017502+        SMARCA2       NM_003070
  15                            hsa_circ_0001901   chr9:138773785-138774005-    CAMSAP1       NM_015447
  16                            hsa_circ_0001917   chrX:41519691-41530783-      CASK          NM_001126055
  17                            hsa_circ_0001955   chr15:64495280-64508912-     CSNK1G1       NM_022048
  18                            hsa_circ_0002191   chr9:97535283-97563284+      C9orf3        NM_001193331
  19                            hsa_circ_0002702   chr9:35546426-35548532+      RUSC2         NM_001135999
  20                            hsa_circ_0003528   chr5:134032815-134044578+    SEC24A        NM_021982
  21                            hsa_circ_0003645   chr16:19656207-19663412+     C16orf62      NM_020314
  22                            hsa_circ_0003892   chr19:11230767-11238761+     LDLR          NM_000527
  23                            hsa_circ_0003923   chr2:238933982-238940895+    UBE2F         NM_080678
  24                            hsa_circ_0003945   chr9:33953282-33956144-      UBAP2         NM_018449
  25                            hsa_circ_0003958   chr7:27668989-27672064-      HIBADH        NM_152740
  26                            hsa_circ_0004004   chr5:172359438-172362313+    ERGIC1        NM_001031711
  27                            hsa_circ_0004976   chr2:25990451-25994409-      ASXL2         NM_018263
  28                            hsa_circ_0005397   chr17:30500849-30503232+     RHOT1         NM_001033568
  29                            hsa_circ_0005785   chr12:110819556-110834257-   ANAPC7        NM_016238
  30                            hsa_circ_0006517   chr3:188202379-188242575+    LPP           NM_005578
  31                            hsa_circ_0006789   chrX:118544152-118544325+    SLC25A43      NM_145305
  32                            hsa_circ_0007196   chr3:50144199-50147121+      RBM5          NM_005778
  33                            hsa_circ_0008274   chr13:96485180-96489456-     UGGT2         NM_020121
  34                            hsa_circ_0008310   chr17:7849045-7849304+       CNTROB        NM_001037144
  35                            hsa_circ_0008563   chr1:21599191-21599404-      ECE1          NM_001113347
  36                            hsa_circ_0008583   chr3:196817782-196846401-    DLG1          NM_004087
  37                            hsa_circ_0009910   chr1:12049221-12052747+      MFN2          NM_014874
  38                            hsa_circ_0012107   chr1:44290402-44303983+      ST3GAL3       NM_174963
  39                            hsa_circ_0013048   chr1:82302569-82372915+      LPHN2         NM_012302
  40                            hsa_circ_0014879   chr1:160206924-160231148-    DCAF8         NR_028103
  41                            hsa_circ_0016404   chr1:212977661-212977993+    TATDN3        NM_001146171
  42                            hsa_circ_0018004   chr10:27024168-27024508+     PDSS1         NM_014317
  43                            hsa_circ_0026143   chr12:49722709-49723237+     TROAP         NM_005480
  44                            hsa_circ_0027478   chr12:69109406-69125499+     NUP107        NM_020401
  45                            hsa_circ_0028196   chr12:110826316-110834257-   ANAPC7        NM_016238
  46                            hsa_circ_0029325   chr12:125270902-125284788-   SCARB1        NM_005505
  47                            hsa_circ_0031132   chr14:21464367-21464870+     METTL17       NM_022734
  48                            hsa_circ_0032704   chr14:76173360-76187046+     TTLL5         NM_015072
  49                            hsa_circ_0033408   chr14:102842986-102931626+   TECPR2        NM_014844
  50                            hsa_circ_0036005   chr15:67004005-67008836+     SMAD6         NR_027654
  51                            hsa_circ_0038718   chr16:27351506-27353580+     IL4R          NM_000418
  52                            hsa_circ_0039053   chr16:30510394-30510810+     ITGAL         NM_002209
  53                            hsa_circ_0043438   chr17:37583953-37584043-     MED1          NM_004774
  54                            hsa_circ_0045006   chr17:59152280-59161925+     BCAS3         NM_001099432
  55                            hsa_circ_0045862   chr17:76082583-76083174+     TNRC6C        NM_001142640
  56                            hsa_circ_0048937   chr19:6934997-6937659+       EMR1          NM_001974
  57                            hsa_circ_0049997   chr19:17626981-17628198+     PGLS          NM_012088
  58                            hsa_circ_0051220   chr19:41884185-41884424+     TMEM91        NM_001098821
  59                            hsa_circ_0051732   chr19:48660270-48660397-     LIG1          NM_000234
  60                            hsa_circ_0060055   chr20:33866724-33872064-     EIF6          NM_181468
  61                            hsa_circ_0062682   chr22:26936754-26937684-     TPST2         NM_001008566
  62                            hsa_circ_0064288   chr3:11348416-11350535+      ATG7          NM_006395
  63                            hsa_circ_0065214   chr3:47466974-47476627-      SCAP          NM_012235
  64                            hsa_circ_0067934   chr3:170013698-170015181+    PRKCI         NM_002740
  65                            hsa_circ_0072088   chr5:32379220-32388780-      ZFR           NM_016107
  66                            hsa_circ_0073271   chr5:88044886-88047860-      MEF2C         NM_002397
  67                            hsa_circ_0074903   chr5:168110970-168112932-    SLIT3         NM_003062
  68                            hsa_circ_0078738   chr6:170033042-170058454-    WDR27         NM_182552
  69                            hsa_circ_0082182   chr7:128317617-128323309+    FAM71F2       NM_001128926
  70                            hsa_circ_0082564   chr7:137569740-137570248-    CREB3L2       NM_194071
  71                            hsa_circ_0083766   chr8:27382878-27394372+      EPHX2         NM_001979
  72                            hsa_circ_0091331   chrX:109310574-109352374+    TMEM164       NM_032227
  73                            hsa_circ_0092283   chr22:36681395-36681695-     MYH9          NM_002473
  74                            hsa_circ_0092298   chr5:178287348-178287568+    ZNF354B       NM_058230
  75                            hsa_circ_0092310   chr6:43467278-43467478+      TJAP1         NM_001146018
  76                            hsa_circ_0092327   chr19:17972481-17972901+     RPL18A        NM_000980
  **Down-regulated circRNAs**                                                                 
  1                             hsa_circ_0003859   chr19:41122794-41125398+     LTBP4         NM_001042544
  2                             hsa_circ_0004913   chr17:62248459-62265775-     TEX2          NM_018469
  3                             hsa_circ_0005428   chr1:47761436-47770668-      STIL          NM_001048166
  4                             hsa_circ_0007762   chr6:147581750-147599340+    STXBP5        NM_001127715
  5                             hsa_circ_0008160   chr21:38439561-38441924-     PIGP          NR_028352
  6                             hsa_circ_0036044   chr15:68434283-68457142+     PIAS1         NM_016166
  7                             hsa_circ_0038929   chr16:29810948-29811369+     KIF22         NM_007317
  8                             hsa_circ_0043302   chr17:36353600-36353765-     LOC440434     NR_036750
  9                             hsa_circ_0051637   chr19:47285639-47285806-     SLC1A5        NM_005628
  10                            hsa_circ_0056548   chr2:135878388-135881816+    RAB3GAP1      NM_001172435
  11                            hsa_circ_0078279   chr6:151226785-151293194+    MTHFD1L       NM_001242767

###### 

Consensus microRNAs (miRNAs) and DECs potentially interact with them.

  MiRNAs            DECs predicted to interact with
  ----------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  hsa-miR-1248      hsa_circ_0032704, hsa_circ_0000673, hsa_circ_0039053, hsa_circ_0016404, hsa_circ_0028196, hsa_circ_0003958, hsa_circ_0004976, hsa_circ_0008583, hsa_circ_0003528, hsa_circ_0001806, hsa_circ_0078279, hsa_circ_0005428
  hsa-miR-1236-3p   hsa_circ_0032704, hsa_circ_0016404, hsa_circ_0027478, hsa_circ_0065214, hsa_circ_0001806, hsa_circ_0065214, hsa_circ_0002191, hsa_circ_0014879, hsa_circ_0007762, hsa_circ_0003859
  hsa-miR-330-5p    hsa_circ_0001338, hsa_circ_0000291, hsa_circ_0005397, hsa_circ_0003892, hsa_circ_0007196, hsa_circ_0082182, hsa_circ_0002702, hsa_circ_0043302, hsa_circ_0026143, hsa_circ_0001955
  hsa-miR-615-5p    hsa_circ_0008563, hsa_circ_0045006, hsa_circ_0092283, hsa_circ_0009910, hsa_circ_0002702, hsa_circ_0001228, hsa_circ_0006789, hsa_circ_0000511, hsa_circ_0003859
  hsa-miR-1299      hsa_circ_0039053, hsa_circ_0002702, hsa_circ_0003645, hsa_circ_0002191, hsa_circ_0056548, hsa_circ_0007762, hsa_circ_0001806, hsa_circ_0001955, hsa_circ_0083766
  hsa-miR-486-3p    hsa_circ_0002702, hsa_circ_0003859, hsa_circ_0001806, hsa_circ_0000554, hsa_circ_0000291, hsa_circ_0001806, hsa_circ_0033408, hsa_circ_0092310
  hsa-miR-370-3p    hsa_circ_0004976, hsa_circ_0003528, hsa_circ_0074903, hsa_circ_0003945, hsa_circ_0001338, hsa_circ_0026143, hsa_circ_0062682
  hsa-miR-589-5p    hsa_circ_0005428, hsa_circ_0000291, hsa_circ_0003892, hsa_circ_0008583, hsa_circ_0002191, hsa_circ_0078279
  hsa-miR-145-5p    hsa_circ_0001955, hsa_circ_0028196, hsa_circ_0083766, hsa_circ_0001489, hsa_circ_0027478, hsa_circ_0005428
  hsa-miR-1286      hsa_circ_0000747, hsa_circ_0026143, hsa_circ_0038718, hsa_circ_0051732, hsa_circ_0003958, hsa_circ_0002702
  hsa-miR-7-5p      hsa_circ_0028196, hsa_circ_0065214, hsa_circ_0005785, hsa_circ_0003892, hsa_circ_0001489, hsa_circ_0092327
  hsa-miR-637       hsa_circ_0016404, hsa_circ_0039053, hsa_circ_0026143, hsa_circ_0004913, hsa_circ_0003892, hsa_circ_0005397
  hsa-miR-377-3p    hsa_circ_0036044, hsa_circ_0003859, hsa_circ_0072088, hsa_circ_0008274, hsa_circ_0003645
  hsa-miR-203a-3p   hsa_circ_0039053, hsa_circ_0013048, hsa_circ_0032704, hsa_circ_0078279
  hsa-miR-1296-5p   hsa_circ_0001955, hsa_circ_0001489, hsa_circ_0001279, hsa_circ_0082564
  hsa-miR-192-5p    hsa_circ_0003528, hsa_circ_0078738, hsa_circ_0007196
  hsa-miR-1256      hsa_circ_0033408, hsa_circ_0002191, hsa_circ_0001955
  hsa-miR-1289      hsa_circ_0049997, hsa_circ_0004976, hsa_circ_0008160
  hsa-miR-215-5p    hsa_circ_0003528, hsa_circ_0078738
  hsa-miR-1261      hsa_circ_0072088, hsa_circ_0009910
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